Market research
ALC.AU Alcidion Group Limited
AU AUD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 135M
- P/E ratio
- Not available
- Analyst target
- 0.1476
- Dividend yield
- Not available
- Beta
- 1.02
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- AU000000ALC6
- Market cap
- 135M
- P/E ratio
- Not available
- Analyst target
- 0.1476
- Dividend yield
- Not available
- Beta
- 1.02
About
About Alcidion Group Limited
Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.
Research context
Alcidion Group Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ALC.AU discussion.
5 years, 6 months ago
Alcidion Group Limited is currently in a long term uptrend where the price is trading 36.3% above its 200 day moving average.
From a valuation standpoint, the stock is 94.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.3.
Alcidion Group Limited's total revenue rose by 36.0% to $11M since the same quarter in the previous year.
Its net income has increased by 22.9% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 100.6% to $-2M since the same quarter in the previous year.
Based on the above factors, Alcidion Group Limited gets an overall score of 4/5.